Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 67 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

67 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 1, 2023 MYGN S 10b5-1 30,000 $19.09 $572,700 291,812 Direct -9.32% Disposed -76.0% (price as of 2026-10-05)
Nov. 1, 2023 MYGN S 10b5-1 30,000 $15.69 $470,700 321,812 Direct -8.53% Disposed -70.8% (price as of 2026-10-05)
March 2, 2023 MYGN S 10b5-1 15,000 $22.55 $338,250 337,885 Direct -4.25% Disposed -79.7% (price as of 2026-10-05)
Jan. 20, 2023 MYGN S 10b5-1 9,400 $20.04 $188,376 364,107 Direct -2.52% Disposed -77.1% (price as of 2026-10-05)
Jan. 18, 2023 MYGN S 10b5-1 600 $20.01 $12,006 373,507 Direct -0.16% Disposed -77.1% (price as of 2026-10-05)
Dec. 27, 2022 MYGN S 10b5-1 20,000 $15.15 $303,000 374,107 Direct -5.07% Disposed -69.8% (price as of 2026-10-05)
Aug. 3, 2021 MYGN S 10b5-1 14,983 $35.14 $526,503 324,942 Direct -4.41% Disposed -87.0% (price as of 2026-10-05)
Aug. 1, 2019 MYGN S 10b5-1 25,000 $41.50 $1,037,500 120,566 Direct -17.17% Disposed -89.0% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Aug. 14, 2026 NEOG Common Stock (Right to Buy) Common Stock (261,702) $11.65 Aug. 14, 2036 261,702 Acquired
Nov. 3, 2025 NEOG Common Stock (Right to Buy) Common Stock (459,713) $6.29 Nov. 3, 2025 459,713 Acquired
June 14, 2024 CDNA Stock Option (right to buy) Common Stock (16,048) · June 14, 2034 16,048 Acquired
June 14, 2024 CDNA Stock Option (right to buy) Common Stock (16,048) $9.35 June 14, 2034 16,048 Acquired
June 13, 2024 CDNA Stock Option (right to buy) Common Stock (9,760) · June 13, 2034 9,760 Acquired
June 13, 2024 CDNA Stock Option (right to buy) Common Stock (9,760) $10.25 June 13, 2034 9,760 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2026 $334,615 $250,000 $1,125,000 $1,125,000 $480,000 · $24,437 $3,339,053

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.